CS
CBIO

Candriam SCA’s Crescent Biopharma CBIO Stock Holding History

Candriam SCA’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-969
Closed -$418K – 797
2019
Q3 		$418K Hold
969
– – 0.01% 699
2019
Q2 		$1.15M Buy
969
+235
+32% +$281K 0.01% 627
2019
Q1 		$915K Buy
+734
New +$840K 0.01% 649
2017
Q2 		– Sell
-1,600
Closed -$869K – 710
2017
Q1 		$869K Hold
1,600
– – 0.02% 585
2016
Q4 		$976K Hold
1,600
– – 0.02% 519
2016
Q3 		$1.14M Hold
1,600
– – 0.03% 470
2016
Q2 		$1.16M Sell
1,600
-499
-24% -$344K 0.03% 409
2016
Q1 		$1.24M Sell
2,099
-101
-5% -$51.8K 0.03% 395
2015
Q4 		$1.26M Hold
2,200
– – 0.03% 361
2015
Q3 		$1.23M Sell
2,200
-150
-6% -$108K 0.03% 411
2015
Q2 		$1.87M Hold
2,350
– – 0.04% 373
2015
Q1 		$1.96M Hold
2,350
– – 0.04% 390
2014
Q4 		$1.69M Buy
+2,350
New +$1.84M 0.04% 378

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return